Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-HuR/ELAVL1 Antibody (R2G52)

Catalog #:   RHH17301 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IF, IHC, IP, WB
Accession: Q15717
Overview

Catalog No.

RHH17301

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000

Target

ELAV-like protein 1, HuR, ELAVL1, Hu-antigen R, HUR

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q15717

Applications

FCM, IF, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2G52

Data Image
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
References

Optimizing respiratory vaccination strategies for Jersey calves: Impact of timing and maternal antibody interference., PMID:40187221

An Effective Prophylactic and Therapeutic Protection Against Botulinum Type A Intoxication in Mice and Rabbits Using a Humanized Monoclonal Antibody., PMID:40137911

Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis., PMID:40095567

Modulated electro-hyperthermia therapy combined with Korean mistletoe extract treatment exerts a strong anti-tumor activity by enhancing cellular and humoral immune responses in mice., PMID:40040867

Development of ELISA Using Phage-Displayed Stx2 Mini-Body for Detection of STEC Antigen in Field Farming Pig Samples., PMID:40005748

m6A eraser ALKBH5/treRNA1/DDX46 axis regulates BCR expression., PMID:39987653

Targeting NINJ1-mediated cell rupture to treat inflammatory diseases., PMID:39953391

Analysis of Changes in Viral Load and Inflammatory Cytokines, as Well as the Occurrence of Secondary Infections, in SFTS Patients Treated with Specific Treatments: A Prospective Multicenter Cohort Study., PMID:39772212

MODELING EARLY-ONSET CANCER KINETICS TO STUDY CHANGES IN UNDERLYING RISK, DETECTION, AND IMPACT OF POPULATION SCREENING., PMID:39677417

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment., PMID:39640896

Immunogenicity and Antibody Persistence of the Inactivated Quadrivalent Influenza Vaccine in Pediatric Patients Post-Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation Versus Healthy Controls., PMID:39591127

Streamlined miRNA loading of surface protein-specific extracellular vesicle subpopulations through electroporation., PMID:39574085

Safety Assessment of Camelid-Derived Single-Domain Antibody as Feed Additive for Juvenile Whiteleg Shrimp (Litopenaeus vannamei) Against White Spot Syndrome Virus., PMID:39457895

A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice., PMID:39352717

HuR (ELAVL1) regulates the CCHFV minigenome and HAZV replication by associating with viral genomic RNA., PMID:39348382

Peptide-Based Nanoparticles Suppress Hepatic Inflammation via Blockage of Human Antigen R., PMID:39344590

Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease., PMID:39252490

Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review., PMID:39213145

Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets., PMID:39201609

CD150‑dependent activation of EBV‑transformed B cells induces the differentiation of peripheral blood monocytes via the secretion of multiple cytokines., PMID:39027993

Rapid Progression of Acute Interstitial Pneumonia in a Patient with Low MDA-5 Antibody Titer., PMID:38961608

ETV5 promotes lupus pathogenesis and follicular helper T cell differentiation by inducing osteopontin expression., PMID:38843187

Effect of Exposure to Particulate Matter on the Ocular Surface in an Experimental Allergic Eye Disease Mouse Model., PMID:38790364

Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype., PMID:38364528

Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study., PMID:38310883

Development of an indirect ELISA system for diagnosis of porcine edema disease using recombinant modified Stx2e antigen., PMID:38285612

Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo., PMID:38061230

Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study., PMID:37977324

Targeting GAS6/AXL signaling improves the response to immunotherapy by restoring the anti-immunogenic tumor microenvironment in gastric cancer., PMID:37952835

Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea., PMID:37946408

A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation., PMID:37925433

A Korean family with RHD*DNT only detectable after anti-D alloimmunization., PMID:37852281

Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR., PMID:37848981

Colocalization of TDP-43 and stress granules at the early stage of TDP-43 aggregation in amyotrophic lateral sclerosis., PMID:37793650

Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147., PMID:37509657

Post-Vaccination Delivery of CpG ODNs Enhances the Th2-Associated Protective Immunity of the Smallpox DNA Vaccine., PMID:37428433

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA., PMID:37425040

Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression., PMID:37370798

Multiplex Protein Imaging through PACIFIC: Photoactive Immunofluorescence with Iterative Cleavage., PMID:37363079

A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice., PMID:37215018

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma., PMID:37196991

Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147., PMID:37090542

Necessity of HuR/ELAVL1 for the activation-induced cytidine deaminase-dependent decrease in topoisomerase 1 in antibody diversification., PMID:37086201

RHD*DNT (RHD*38) Showing D-Positive Reactivity on Rhesus D Typing and Forming Anti-D Antibody., PMID:37080757

Circulating markers of microbial translocation and host response to bacteria with risk of colorectal cancer: a prospective, nested case-control study in men., PMID:37075493

CRISPR-clear imaging of melanin-rich B16-derived solid tumors., PMID:37016073

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity., PMID:37005480

In situ silver nanoparticle development for molecular-specific biological imaging via highly accessible microscopies., PMID:36926569

Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma., PMID:36892581

In Vitro Expansion of Vδ1+ T Cells from Cord Blood by Using Artificial Antigen-Presenting Cells and Anti-CD3 Antibody., PMID:36851283

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HuR/ELAVL1 Antibody (R2G52) [RHH17301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only